Hysteroscopic endometrial resection

Bratschi HU, H U Bratschi
Contributions to gynecology and obstetrics · 2000 · vol. 20 , pp. 121–136 · doi:10.1159/000060291 · PMID:11791274 · W1502692832
Review OA: closed CC0 ⤵ 2 in-corpus citations
View on OpenAlex View on PubMed View at publisher
⚙ AI-generated summary by gemini-2.5-flash-lite, 2026-07-18 ⓘ

This paper describes hysteroscopic endometrial resection as a menorrhagia treatment preserving the uterus in most patients, detailing technique, safety, outcomes, and enhanced success with LNG-IUD, especially in adenomyosis.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

Endometrial resection (TRCE) is a well-examined alternative therapy to hysterectomy in the treatment of menorrhagia that preserves the uterus at long term in at least 70% of patients. The technique and safety considerations are described and an overview of the existing evidence is given. Complication rates (2.5%) and performance of the personal series of 465 operative hysteroscopies including 244 endometrial resections with a follow-up of at least 18 months are shown. 3.3% of patients with endometrial resection needed a hysterectomy up to now (follow-up 18-90 months). The combination of endometrial resection and the insertion of the levonorgestrel hormone-releasing intrauterine device (LNG-IUD) is described. Especially in patients with adenomyosis, the combination of LNG-IUD with endometrial resection augments the success rate. 96 of 99 patients with the combined therapy (TRCE and LNG-IUD) and a follow-up of 18-48 months still have their uterus.

My notes (saved in your browser only)

Condition tags

adenomyosis

MeSH descriptors

Endometrium Hysteroscopy Menorrhagia Endometrium Endometrium Female Female Humans Humans Hysteroscopy Hysteroscopy Hysteroscopy Hysteroscopy Intrauterine Devices Intrauterine Devices Levonorgestrel Levonorgestrel Levonorgestrel Menorrhagia Menorrhagia

Citation neighborhood (2-hop)

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. Outer rings show 2-hop neighbours — papers reached through the immediate citers/citees. [ collapse to 1-hop ]

References (26)

Cited by (2)

Source provenance

europepmc
last seen: 2026-10-15T06:08:49.021275+00:00
openalex
last seen: 2026-06-10T17:14:06.276822+00:00
pubmed
last seen: 2026-10-08T21:00:15.595027+00:00
unpaywall
last seen: 2026-10-15T06:24:24.424788+00:00
License: CC0 · commercial use OK